Intelligent Lung Ultrasound Provides Crucial Support for COVID-19 Testing Within Minutes
By HospiMedica International staff writers Posted on 03 Jun 2021 |
Image: Column 1 and 2 show lung ultrasounds without and with annotated COVID-19 biomarkers (orange: moderate, red: severe). Columns 3 and 4 respectively show the semantic segmentations and contours of COVID-19 markers by means of deep learning analysis (Photo courtesy of Eindhoven University of Technology)
Using fairly simple ultrasound machines that are enhanced with artificial intelligence (AI) could make it possible to establish whether a patient is suffering from severe lung disease, possibly COVID-19, within a few minutes.
A research team at Eindhoven University of Technology (Eindhoven, Netherlands) and the University of Trento (Trento, Italy) has been able to translate the expertise of top lung specialists into a software update for these ultrasound machines. This enables relative laymen to interpret the images in a manageable and comparatively inexpensive manner, just like the world’s best lung experts. The solution also offers various advantages over alternative imaging technologies such as CT or MRI: there are many more machines available (including in developing countries and rural areas), these are portable and manageable, do not use radioactive radiation (as with CT), have a minimal risk of contamination through the use of a cover around the sensor, and are comparatively cheap.
Additionally, these image analyses support a diagnosis that ultimately has to be made by the doctor. Further research is needed to determine with absolute certainty whether the lung deficiency is caused by COVID-19 or another lung disease such as severe pneumonia. In addition, more research is needed to be able to perform the complete diagnosis using this intelligent lung ultrasound system. The new technology will be offered to hospitals and the software update could eventually be installed directly on ultrasound machines, so that doctors have everything at their disposal, in real-time.
“With artificial intelligence, the most important biomarkers of severe lung diseases such as COVID-19 can be accurately determined on a lung ultrasound that visualizes the abnormalities at the edge of the lung and the changes in the structure of the network of pulmonary alveoli and interstitial tissue,” said Ruud van Sloun, Assistant Professor and researcher at Eindhoven University of Technology. “And because it’s a program which learns, it becomes even smarter with each new use, allowing it to even more accurately determine whether or not the patient may have COVID-19. We’re very optimistic regarding its quick application in hospitals and emergency rooms.”
Related Links:
Eindhoven University of Technology
University of Trento
A research team at Eindhoven University of Technology (Eindhoven, Netherlands) and the University of Trento (Trento, Italy) has been able to translate the expertise of top lung specialists into a software update for these ultrasound machines. This enables relative laymen to interpret the images in a manageable and comparatively inexpensive manner, just like the world’s best lung experts. The solution also offers various advantages over alternative imaging technologies such as CT or MRI: there are many more machines available (including in developing countries and rural areas), these are portable and manageable, do not use radioactive radiation (as with CT), have a minimal risk of contamination through the use of a cover around the sensor, and are comparatively cheap.
Additionally, these image analyses support a diagnosis that ultimately has to be made by the doctor. Further research is needed to determine with absolute certainty whether the lung deficiency is caused by COVID-19 or another lung disease such as severe pneumonia. In addition, more research is needed to be able to perform the complete diagnosis using this intelligent lung ultrasound system. The new technology will be offered to hospitals and the software update could eventually be installed directly on ultrasound machines, so that doctors have everything at their disposal, in real-time.
“With artificial intelligence, the most important biomarkers of severe lung diseases such as COVID-19 can be accurately determined on a lung ultrasound that visualizes the abnormalities at the edge of the lung and the changes in the structure of the network of pulmonary alveoli and interstitial tissue,” said Ruud van Sloun, Assistant Professor and researcher at Eindhoven University of Technology. “And because it’s a program which learns, it becomes even smarter with each new use, allowing it to even more accurately determine whether or not the patient may have COVID-19. We’re very optimistic regarding its quick application in hospitals and emergency rooms.”
Related Links:
Eindhoven University of Technology
University of Trento
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans